March 17, 2023
Takeda Pharmaceutical has updated its peak sales estimate for its tetravalent dengue vaccine Qdenga to US$1.6-2 billion from the previous target of US$700 million-1.6 billion, the company’s global portfolio president Ramona Sequeira said on March 16. On an online investor...read more